Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOADEX: Dexamethasone Implant Loading Dose in Diabetic Macular Edema
2019-003092-18Phase 2Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexamethasone in diabetic macular edema (DME), sponsored by Hospices Civils de Lyon. Primary endpoints: Visual acuity at 52 weeks and Time to best visual acuity. Started Oct 2019; status: active.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2019-003092-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003092-18.